title: Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumour necrosis factor as therapeutic modalities for concanavalin A induced hepatitis in mice.
abstract: OBJECTIVE
  It has been shown that synthetic non-peptidic analogues of Arg-Gly-Asp, a major cell adhesive ligand of extracellular matrix, prevented an increase in serum aminotransferase activity, as a manifestation of concanavalin A induced liver damage in mice. This study examined the effects of an Arg-Gly-Asp mimetic on liver histology and cytokine release in response to concanavalin A administration, and the efficacy of soluble receptor of tumour necrosis factor (TNF) alpha in preventing hepatitis in this model of liver injury.
  
  
  METHODS
  Mice were pretreated with either the Arg-Gly-Asp mimetic SF-6,5 or recombinant soluble receptor of TNF alpha before their inoculation with 10 mg/kg concanavalin A. Liver enzymes, histology, and the serum values of TNF alpha and interleukin (IL)6 were examined.
  
  
  RESULTS
  The histopathological damage in the liver, and the concanavalin A induced release of TNF alpha and IL6 were significantly inhibited by the synthetic Arg-Gly-Asp mimetic (p < 0.001). Liver injury, manifested by the increase in serum aminotransferase and cytokines, as well as by histological manifestations of hepatic damage, was effectively prevented by pretreatment of the mice with the soluble TNF receptor (p < 0.001).
  
  
  CONCLUSIONS
  This study confirms the efficacy of a synthetic Arg-Gly-Asp mimetic and soluble TNF receptor in the prevention of immune mediated liver damage in mice.
authors.affiliation: Department of Gastroenterology, E Wolfson Medical Centre Holon, Israel.
authors.forename: R
authors.initials: R
authors.lastname: Bruck
authors.forename: H
authors.initials: H
authors.lastname: Shirin
authors.forename: R
authors.initials: R
authors.lastname: Hershkoviz
authors.forename: O
authors.initials: O
authors.lastname: Lider
authors.forename: G
authors.initials: G
authors.lastname: Kenet
authors.forename: H
authors.initials: H
authors.lastname: Aeed
authors.forename: Z
authors.initials: Z
authors.lastname: Matas
authors.forename: L
authors.initials: L
authors.lastname: Zaidel
authors.forename: Z
authors.initials: Z
authors.lastname: Halpern
mesh_terms: D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001219:Aspartate Aminotransferases / Q000097:blood; D003208:Concanavalin A; D006146:Guanidines / Q000494:pharmacology*; D006520:Hepatitis, Animal / Q000139:chemically induced / Q000378:metabolism / Q000517:prevention & control*; D015850:Interleukin-6 / Q000097:blood; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D018124:Receptors, Tumor Necrosis Factor; D011994:Recombinant Proteins / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D014631:Valerates / Q000494:pharmacology*
chemical_list: D006146:Guanidines; D015850:Interleukin-6; D018124:Receptors, Tumor Necrosis Factor; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D014631:Valerates; D003208:Concanavalin A; C084660:SF 6,5; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase